If a patient has been off mixed amphetamine salts (Adderall) 20 mg daily for five months, should the medication be restarted at the same dose or at a lower dose with gradual titration back to the original dose over a month?

Restarting Adderall After 5-Month Discontinuation

After a 5-month discontinuation of Adderall 20 mg daily, you should restart at a low dose (5 mg once or twice daily) and titrate upward over 2-4 weeks to the previous therapeutic dose, rather than immediately resuming the full 20 mg dose. This approach minimizes the risk of adverse effects and allows for reassessment of the optimal therapeutic dose 1, 2.

Rationale for Low-Dose Restart

Tolerance Loss and Physical Dependence

• After 5 months off medication, the patient has likely lost any tolerance that developed during previous treatment 2
• Physical dependence resolves after prolonged discontinuation, meaning the body is no longer adapted to the medication 2
• Restarting at the full 20 mg dose may produce more pronounced side effects (insomnia, anorexia, anxiety, cardiovascular effects) than the patient previously experienced 1

FDA-Approved Titration Protocol

The FDA label for Adderall explicitly recommends starting low regardless of prior treatment history 2:

• For patients 6 years and older: Start with 5 mg once or twice daily
• Increase in increments of 5 mg at weekly intervals until optimal response is obtained 2
• This applies to both treatment-naïve patients and those restarting therapy

Recommended Titration Schedule

Week-by-Week Approach

Following established clinical practice guidelines 1:

• Week 1: Start with 5 mg once or twice daily (total 5-10 mg/day)
• Week 2: Increase to 10 mg once or twice daily if tolerated (total 10-20 mg/day)
• Week 3-4: Continue titrating by 5 mg increments weekly until reaching the previous effective dose of 20 mg daily 1

Monitoring During Titration

• Assess ADHD symptoms and side effects weekly during dose adjustments 1
• Contact can be maintained by telephone during the titration phase 1
• Monitor vital signs (blood pressure, pulse) and weight at each dose increase 1
• Systematically assess for common side effects: insomnia, decreased appetite, headaches, anxiety, cardiovascular changes 1

Important Clinical Considerations

The Previous Dose May Not Be Optimal

• After 5 months, the patient's clinical situation may have changed
• The original 20 mg dose may have been either too high or too low for optimal symptom control 1
• Retitration provides an opportunity to identify the true optimal dose rather than assuming the previous dose was correct 1

Risk of Misuse and Diversion

• Amphetamines are Schedule II controlled substances with high abuse potential 2
• After a 5-month gap, reassess for any signs of previous misuse or diversion
• Starting low helps identify if the patient is seeking medication for therapeutic versus non-therapeutic purposes 2

Cardiovascular Safety

• Before restarting, reassess for cardiac disease through careful history and physical examination 2
• This is particularly important if the discontinuation was due to side effects or if 5 months have passed since last cardiovascular assessment 2

Common Pitfalls to Avoid

• Do not restart at 20 mg immediately: This violates FDA guidance and increases risk of adverse effects 2
• Do not rush titration: The 2-4 week titration period is standard practice and allows proper assessment 1
• Do not assume the previous dose was optimal: Use this as an opportunity to optimize therapy 1
• Do not neglect side effect monitoring: Weekly assessment during titration is essential to catch problems early 1